CEACAM5 and neoplasm: The [64Cu]Cu-DO3A-M5A∆CH2-C5 was evaluated for CEA-positive tumor PET imaging at serial time points, pharmacokinetics and a terminal biodistribution study conducted in two CEA-positive colorectal cancer mouse models.